{"id":3794,"date":"2026-06-06T08:26:26","date_gmt":"2026-06-06T15:26:26","guid":{"rendered":"https:\/\/xpharma.com.cn\/?p=3794"},"modified":"2026-06-06T08:26:28","modified_gmt":"2026-06-06T15:26:28","slug":"chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review","status":"publish","type":"post","link":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/","title":{"rendered":"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review."},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Naldemedine, developed by Shionogi and commercialized in China by Chia Tai Tianqing, has been officially approved for marketing by the NMPA (acceptance number: JXHS2500060). It is specifically indicated for the treatment of opioid-induced constipation (OIC), filling a gap in precise clinical treatment in China.<strong><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Naldemedine is the world&#8217;s first approved oral selective peripheral mu-opioid receptor antagonist, with a precise and unique mechanism of action. The drug specifically blocks the binding of opioids to mu receptors in the gut, fundamentally reversing the pathological effects of opioids that inhibit gastrointestinal motility and reduce intestinal fluid secretion. It rapidly restores normal physiological rhythm of the intestine, efficiently improving OIC symptoms, while having no impact on the central analgesic effects of opioids, balancing both efficacy and safety.<strong><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This new drug has been approved for marketing in multiple countries and regions, including the United States, the European Union, Japan, and Hong Kong (China). Its domestic launch process has been steadily advancing. In 2022, it was introduced to the Hainan Lecheng Medical Pilot Zone as a clinically urgently needed drug. In April 2026, leveraging Guangdong&#8217;s &#8220;Hong Kong-Macao Drug and Medical Device Connect&#8221; policy, it was first made available at designated medical institutions in the Guangdong-Hong Kong-Macao Greater Bay Area. Now, with formal approval from the NMPA, it has achieved compliant nationwide marketing in China.<strong><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Buy Symproic\u00ae\uff08Naldemedine\uff09\u00a0online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Naldemedine, developed by Shionogi and commercialized in China by Chia Tai Tianqing, has been officially approved for marketing by the NMPA (acceptance number: JXHS2500060). It is specifically indicated for the treatment of opioid-induced constipation (OIC), filling a gap in precise clinical treatment in China. Naldemedine is the world&#8217;s first approved oral selective peripheral mu-opioid receptor [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2775,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-3794","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China<\/title>\n<meta name=\"description\" content=\"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing\uff1asymproicnaldemedinehas-been-formally-accepted-for-review\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China\" \/>\n<meta property=\"og:description\" content=\"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing\uff1asymproicnaldemedinehas-been-formally-accepted-for-review\/\" \/>\n<meta property=\"og:site_name\" content=\"Xpharma China\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/61590027634719\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-06T15:26:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-06T15:26:28+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/chiatai-tianqing.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"344\" \/>\n\t<meta property=\"og:image:height\" content=\"146\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"xpharmanews\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:site\" content=\"@Xpharma007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"xpharmanews\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/\"},\"author\":{\"name\":\"xpharmanews\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\"},\"headline\":\"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review.\",\"datePublished\":\"2026-06-06T15:26:26+00:00\",\"dateModified\":\"2026-06-06T15:26:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/\"},\"wordCount\":261,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/chiatai-tianqing.jpg\",\"articleSection\":[\"Approved News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/#respond\"]}]},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/\",\"name\":\"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/chiatai-tianqing.jpg\",\"datePublished\":\"2026-06-06T15:26:26+00:00\",\"dateModified\":\"2026-06-06T15:26:28+00:00\",\"description\":\"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/chiatai-tianqing.jpg\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/chiatai-tianqing.jpg\",\"width\":344,\"height\":146,\"caption\":\"Symproic\u00aeNaldemedine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/news\\\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\\\/\\\/xpharma.com.cn\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#website\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"name\":\"Xpharma China - International Pharmaceutical wholesaler and retailer\",\"description\":\"Xpharma China\",\"publisher\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xpharma.com.cn\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#organization\",\"name\":\"Xpharma China\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"contentUrl\":\"https:\\\/\\\/xpharma.com.cn\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/logo.gif\",\"width\":679,\"height\":166,\"caption\":\"Xpharma China\"},\"image\":{\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/61590027634719\\\/\",\"https:\\\/\\\/x.com\\\/Xpharma007\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/xpharma.com.cn\\\/#\\\/schema\\\/person\\\/c292b26c0a3311036ce0f5ab28a1ea05\",\"name\":\"xpharmanews\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g\",\"caption\":\"xpharmanews\"},\"url\":\"https:\\\/\\\/xpharma.com.cn\\\/index.php\\\/author\\\/xpharmanews\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China","description":"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing\uff1asymproicnaldemedinehas-been-formally-accepted-for-review\/","og_locale":"en_US","og_type":"article","og_title":"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China","og_description":"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China","og_url":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing\uff1asymproicnaldemedinehas-been-formally-accepted-for-review\/","og_site_name":"Xpharma China","article_publisher":"https:\/\/www.facebook.com\/61590027634719\/","article_published_time":"2026-06-06T15:26:26+00:00","article_modified_time":"2026-06-06T15:26:28+00:00","og_image":[{"width":344,"height":146,"url":"http:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/chiatai-tianqing.jpg","type":"image\/jpeg"}],"author":"xpharmanews","twitter_card":"summary_large_image","twitter_creator":"@Xpharma007","twitter_site":"@Xpharma007","twitter_misc":{"Written by":"xpharmanews","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/#article","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/"},"author":{"name":"xpharmanews","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05"},"headline":"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review.","datePublished":"2026-06-06T15:26:26+00:00","dateModified":"2026-06-06T15:26:28+00:00","mainEntityOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/"},"wordCount":261,"commentCount":0,"publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/chiatai-tianqing.jpg","articleSection":["Approved News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/#respond"]}]},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/","url":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/","name":"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China","isPartOf":{"@id":"https:\/\/xpharma.com.cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/#primaryimage"},"image":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/#primaryimage"},"thumbnailUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/chiatai-tianqing.jpg","datePublished":"2026-06-06T15:26:26+00:00","dateModified":"2026-06-06T15:26:28+00:00","description":"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review. - Xpharma China","breadcrumb":{"@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/#primaryimage","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/chiatai-tianqing.jpg","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/05\/chiatai-tianqing.jpg","width":344,"height":146,"caption":"Symproic\u00aeNaldemedine"},{"@type":"BreadcrumbList","@id":"https:\/\/xpharma.com.cn\/index.php\/news\/chia-tai-tianqing%ef%bc%9asymproicnaldemedinehas-been-formally-accepted-for-review\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/xpharma.com.cn\/"},{"@type":"ListItem","position":2,"name":"Chia Tai Tianqing\uff1aSymproic\u00aeNaldemedinehas been formally accepted for review."}]},{"@type":"WebSite","@id":"https:\/\/xpharma.com.cn\/#website","url":"https:\/\/xpharma.com.cn\/","name":"Xpharma China - International Pharmaceutical wholesaler and retailer","description":"Xpharma China","publisher":{"@id":"https:\/\/xpharma.com.cn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xpharma.com.cn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/xpharma.com.cn\/#organization","name":"Xpharma China","url":"https:\/\/xpharma.com.cn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/","url":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","contentUrl":"https:\/\/xpharma.com.cn\/wp-content\/uploads\/2026\/04\/logo.gif","width":679,"height":166,"caption":"Xpharma China"},"image":{"@id":"https:\/\/xpharma.com.cn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/61590027634719\/","https:\/\/x.com\/Xpharma007"]},{"@type":"Person","@id":"https:\/\/xpharma.com.cn\/#\/schema\/person\/c292b26c0a3311036ce0f5ab28a1ea05","name":"xpharmanews","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5441929ebdec5e836942790743ce7c64c33152cf17fba039e0d79b52418f025f?s=96&d=mm&r=g","caption":"xpharmanews"},"url":"https:\/\/xpharma.com.cn\/index.php\/author\/xpharmanews\/"}]}},"_links":{"self":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/3794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/comments?post=3794"}],"version-history":[{"count":1,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/3794\/revisions"}],"predecessor-version":[{"id":3795,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/posts\/3794\/revisions\/3795"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media\/2775"}],"wp:attachment":[{"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/media?parent=3794"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/categories?post=3794"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xpharma.com.cn\/index.php\/wp-json\/wp\/v2\/tags?post=3794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}